Zkusit zdarma
Inhibrx Biosciences, Inc.

Inhibrx Biosciences, Inc.

INBX
Cena:
$ 101.32
-9.25 (-8.37%)
Valuace
70
Růst
0
Zdraví
73
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Inhibrx Reports First Quarter 2026 Financial Results

Inhibrx Reports First Quarter 2026 Financial Results

16:02 14-05-2026

SAN DIEGO, May 14, 2026 /PRNewswire/ -- Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx" or the "...

Inhibrx Cancer Treatment Shows High Response Rates In Head And Neck Cancer Study

Inhibrx Cancer Treatment Shows High Response Rates In Head And Neck Cancer Study

13:57 11-05-2026

Inhibrx Biosciences, Inc. (NASDAQ:INBX) shares are trading higher on Monday as the company is report...

Inhibrx Biosciences' INBRX-106 Combo Tops KEYTRUDA Alone in Phase 2 Cancer Study

Inhibrx Biosciences' INBRX-106 Combo Tops KEYTRUDA Alone in Phase 2 Cancer Study

12:09 11-05-2026

Inhibrx Biosciences NASDAQ: INBX reported interim randomized Phase 2 data for INBRX-106 in combinati...

Inhibrx Reports Interim Phase 2 Data for INBRX-106 in First-Line HNSCC; Initial Results Demonstrate Potential Costimulatory Benefit Over PD-1 Monotherapy

Inhibrx Reports Interim Phase 2 Data for INBRX-106 in First-Line HNSCC; Initial Results Demonstrate Potential Costimulatory Benefit Over PD-1 Monotherapy

8:00 11-05-2026

Interim analyses show INBRX-106 + pembrolizumab achieved a 44.0% confirmed Objective Response Rate ...

Inhibrx To Host Webcast Presentation to Provide Clinical Update on INBRX-106 HexAgon Study in First Line HNSCC

Inhibrx To Host Webcast Presentation to Provide Clinical Update on INBRX-106 HexAgon Study in First Line HNSCC

16:00 08-05-2026

– Event to be webcast live on Monday, May 11, 2026, at 5:30 a.m. PT – SAN DIEGO, May 8, 2026 /PR...

INBX Stock Up on Upbeat Clinical Update From Colorectal Cancer Study

INBX Stock Up on Upbeat Clinical Update From Colorectal Cancer Study

10:36 23-04-2026

Inhibrx Biosciences stock surges after phase I/II CRC data of ozekibart show strong response rates a...

Inhibrx: Spinoff Rumors Send Shares Soaring - Stunning Bull Run Can Continue

Inhibrx: Spinoff Rumors Send Shares Soaring - Stunning Bull Run Can Continue

17:36 22-04-2026

Inhibrx Biosciences, Inc. has surged nearly 40% amid rumors of Big Pharma interest in joint spinoffs...

Large Drugmakers Eye Inhibrx Cancer Drugs Valued Over $8 Billion, Stock Surges

Large Drugmakers Eye Inhibrx Cancer Drugs Valued Over $8 Billion, Stock Surges

14:20 22-04-2026

Inhibrx Biosciences Inc. (NASDAQ:INBX) is attracting interest from major drugmakers for its experime...

Exclusive: Merck, rivals eye deal for Inhibrx experimental cancer drug tied to Keytruda, sources say

Exclusive: Merck, rivals eye deal for Inhibrx experimental cancer drug tied to Keytruda, sources say

7:02 22-04-2026

Inhibrx Biosciences has drawn interest from drugmakers including Merck & Co , Germany's Merck KGaA a...

Inhibrx Provides Clinical Update on Ozekibart (INBRX-109) in Late Line Colorectal Cancer

Inhibrx Provides Clinical Update on Ozekibart (INBRX-109) in Late Line Colorectal Cancer

16:05 21-04-2026

SAN DIEGO, April 21, 2026 /PRNewswire/ -- Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx" or the...

Inhibrx To Host Webcast Presentation to Provide Clinical Update on Ozekibart (INBRX-109) in Late Line Colorectal Cancer

Inhibrx To Host Webcast Presentation to Provide Clinical Update on Ozekibart (INBRX-109) in Late Line Colorectal Cancer

17:03 20-04-2026

– Event to be webcast live on Tuesday, April 21, 2026, at 1:30 p.m. PT – SAN DIEGO, April 20, 20...

Inhibrx Biosciences, Inc. (NASDAQ:INBX) Receives $150.00 Consensus Target Price from Analysts

Inhibrx Biosciences, Inc. (NASDAQ:INBX) Receives $150.00 Consensus Target Price from Analysts

1:09 14-04-2026

Inhibrx Biosciences, Inc. (NASDAQ: INBX - Get Free Report) has received a consensus rating of "Hold"...

SG Americas Securities LLC Invests $1.27 Million in Inhibrx Biosciences, Inc. $INBX

SG Americas Securities LLC Invests $1.27 Million in Inhibrx Biosciences, Inc. $INBX

4:47 08-04-2026

SG Americas Securities LLC acquired a new position in Inhibrx Biosciences, Inc. (NASDAQ: INBX) in th...

Inhibrx Reports Fourth Quarter and Fiscal Year 2025 Financial Results

Inhibrx Reports Fourth Quarter and Fiscal Year 2025 Financial Results

16:00 19-03-2026

SAN DIEGO, March 19, 2026 /PRNewswire/ -- Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx" or the...

7,388 Shares in Inhibrx Biosciences, Inc. $INBX Acquired by Dynamic Technology Lab Private Ltd

7,388 Shares in Inhibrx Biosciences, Inc. $INBX Acquired by Dynamic Technology Lab Private Ltd

4:06 13-03-2026

Dynamic Technology Lab Private Ltd bought a new position in Inhibrx Biosciences, Inc. (NASDAQ: INBX)...

Inhibrx Biosciences, Inc. $INBX Shares Sold by Credit Industriel ET Commercial

Inhibrx Biosciences, Inc. $INBX Shares Sold by Credit Industriel ET Commercial

4:28 16-02-2026

Credit Industriel ET Commercial reduced its position in Inhibrx Biosciences, Inc. (NASDAQ: INBX) by ...

Inhibrx: Ozekibart Beyond Chondrosarcoma, With Other Targeted Indications, Too

Inhibrx: Ozekibart Beyond Chondrosarcoma, With Other Targeted Indications, Too

15:09 13-01-2026

Inhibrx Biosciences, Inc. remains a Strong Buy, driven by multiple near-term catalysts, notably the ...

Why Inhibrx's Recent Strength May Not Be Built to Last

Why Inhibrx's Recent Strength May Not Be Built to Last

7:33 24-12-2025

Inhibrx (NASDAQ: INBX) has staged a sharp rally after reporting positive topline results from its re...

Inhibrx Biosciences Provides Progress Updates on the INBRX-106 Program and the Expansion Cohorts of the ozekibart (INBRX-109) Program

Inhibrx Biosciences Provides Progress Updates on the INBRX-106 Program and the Expansion Cohorts of the ozekibart (INBRX-109) Program

17:00 16-12-2025

SAN DIEGO , Dec. 16, 2025 /PRNewswire/ -- Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx" or the...

Inhibrx Biosciences (NASDAQ:INBX) Reaches New 52-Week High – Here’s Why

Inhibrx Biosciences (NASDAQ:INBX) Reaches New 52-Week High – Here’s Why

4:14 05-12-2025

Inhibrx Biosciences, Inc. (NASDAQ: INBX - Get Free Report) reached a new 52-week high during mid-day...

close

INHIBRX BIOSCIENCES PROVIDES PROGRESS UPDATES ON THE INBRX-106 PROGRAM AND THE EXPANSION COHORTS OF THE OZEKIBART (INBRX-109) PROGRAM

16-12-2025
SAN DIEGO , DEC. 16, 2025 /PRNEWSWIRE/ -- INHIBRX BIOSCIENCES, INC. (NASDAQ: INBX) ("INHIBRX" OR THE...
Více zde

INHIBRX REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS

14-11-2025
SAN DIEGO , NOV. 14, 2025 /PRNEWSWIRE/ -- INHIBRX BIOSCIENCES, INC. (NASDAQ: INBX) ("INHIBRX" OR THE...
Více zde

INHIBRX ANNOUNCES PARTICIPATION IN UPCOMING SCIENTIFIC CONFERENCES

04-11-2025
SAN DIEGO , NOV. 4, 2025 /PRNEWSWIRE/ -- INHIBRX BIOSCIENCES, INC. (NASDAQ: INBX) ("INHIBRX" OR THE...
Více zde

INHIBRX BIOSCIENCES REPORTS POSITIVE TOPLINE RESULTS FROM ITS REGISTRATIONAL TRIAL OF OZEKIBART (INBRX-109) IN CHONDROSARCOMA AND PROVIDES UPDATES ON COLORECTAL CANCER AND EWING SARCOMA EXPANSION COHORTS

23-10-2025
OZEKIBART MEETS ITS PRIMARY ENDPOINT IN CHONDROSARCOMA, DEMONSTRATING A STATISTICALLY SIGNIFICANT AN...
Více zde

INHIBRX TO HOST WEBCAST PRESENTATION OF TOPLINE RESULTS FROM ITS REGISTRATIONAL TRIAL OF OZEKIBART (INBRX-109) IN CHONDROSARCOMA AND TO PROVIDE UPDATES ON COLORECTAL CANCER AND EWING SARCOMA EXPANSION COHORTS

22-10-2025
– EVENT TO BE WEBCAST LIVE ON THURSDAY, OCTOBER 23, 2025 AT 1:30 P.M. PT – SAN DIEGO , OCT. 22, ...
Více zde

INHIBRX REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS

13-08-2025
SAN DIEGO , AUG. 13, 2025 /PRNEWSWIRE/ -- INHIBRX BIOSCIENCES, INC. (NASDAQ: INBX) ("INHIBRX" OR THE...
Více zde

INHIBRX REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS

14-05-2025
SAN DIEGO , MAY 14, 2025 /PRNEWSWIRE/ -- INHIBRX BIOSCIENCES, INC. (NASDAQ: INBX) ("INHIBRX" OR THE...
Více zde

INHIBRX BIOSCIENCES ANNOUNCES DEPARTURE OF CSO AND APPOINTMENTS OF NEW CSO AND PRESIDENT

01-04-2025
SAN DIEGO , APRIL 1, 2025 /PRNEWSWIRE/ -- INHIBRX BIOSCIENCES, INC. (NASDAQ: INBX) ("INHIBRX" OR THE...
Více zde

INHIBRX REPORTS FOURTH QUARTER AND FISCAL YEAR 2024 FINANCIAL RESULTS

17-03-2025
SAN DIEGO , MARCH 17, 2025 /PRNEWSWIRE/ -- INHIBRX BIOSCIENCES, INC. (NASDAQ: INBX) ("INHIBRX" OR TH...
Více zde

INHIBRX BIOSCIENCES ANNOUNCES PRELIMINARY DATA FROM THE PHASE 1 TRIAL OF OZEKIBART (INBRX-109) FOR THE TREATMENT OF COLORECTAL CANCER

21-01-2025
SAN DIEGO , JAN. 21, 2025 /PRNEWSWIRE/ -- INHIBRX BIOSCIENCES, INC. (NASDAQ: INBX) ("INHIBRX" OR THE...
Více zde

INHIBRX BIOSCIENCES ANNOUNCES LOAN AGREEMENT WITH OXFORD FINANCE

13-01-2025
SAN DIEGO , JAN. 13, 2025 /PRNEWSWIRE/ -- INHIBRX BIOSCIENCES, INC. ("INHIBRX" OR THE "COMPANY") (NA...
Více zde

INHIBRX BIOSCIENCES REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS

14-11-2024
SAN DIEGO , NOV. 14, 2024 /PRNEWSWIRE/ -- INHIBRX BIOSCIENCES, INC. (NASDAQ: INBX) ("INHIBRX BIOSCIE...
Více zde

INHIBRX PREVAILS IN TRADE SECRET CASE, REAFFIRMING ITS COMMITMENT TO INTEGRITY AND INNOVATION

04-11-2024
SAN DIEGO , NOV. 4, 2024 /PRNEWSWIRE/ -- INHIBRX BIOSCIENCES, INC. (NASDAQ: INBX) ("INHIBRX" OR THE ...
Více zde

INHIBRX BIOSCIENCES REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS AND RECENT CORPORATE HIGHLIGHTS

13-08-2024
SAN DIEGO , AUG. 13, 2024 /PRNEWSWIRE/ -- INHIBRX BIOSCIENCES, INC. (NASDAQ: INBX) ("INHIBRX BIOSCIE...
Více zde

INHIBRX INC. STOCKHOLDERS APPROVE SALE OF INBRX-101 TO SANOFI

24-05-2024
SAN DIEGO , MAY 24, 2024 /PRNEWSWIRE/ -- INHIBRX, INC. (NASDAQ: INBX) ("INHIBRX," OR THE "COMPANY"...
Více zde

INHIBRX, INC. ANNOUNCES UPDATED WHEN-ISSUED TRADING DATE FOR ANTICIPATED SPIN-OFF

10-05-2024
SAN DIEGO , MAY 10, 2024 /PRNEWSWIRE/ -- INHIBRX, INC. (NASDAQ: INBX) ("INHIBRX," OR THE "COMPANY") ...
Více zde

INHIBRX INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: KAHN SWICK & FOTI, LLC INVESTIGATES ADEQUACY OF PRICE AND PROCESS IN PROPOSED SALE OF INHIBRX, INC. - INBX

09-05-2024
NEW ORLEANS--(BUSINESS WIRE)--FORMER ATTORNEY GENERAL OF LOUISIANA CHARLES C. FOTI, JR., ESQ. AND TH...
Více zde

INHIBRX, INC. ANNOUNCES RECORD DATE AND EXPECTED DISTRIBUTION TIME FOR ANTICIPATED SPIN-OFF AND THE EXPECTED MERGER EFFECTIVE TIME FOR ANTICIPATED MERGER

08-05-2024
SAN DIEGO , MAY 8, 2024 /PRNEWSWIRE/ -- INHIBRX, INC. (NASDAQ: INBX) ("INHIBRX," OR THE "COMPANY") T...
Více zde

INHIBRX REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIAL RESULTS

28-02-2024
SAN DIEGO, FEB. 28, 2024 /PRNEWSWIRE/ -- INHIBRX, INC. (NASDAQ: INBX) ("INHIBRX" OR THE "COMPANY"), ...
Více zde

INHIBRX INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: KAHN SWICK & FOTI, LLC INVESTIGATES ADEQUACY OF PRICE AND PROCESS IN PROPOSED SALE OF INHIBRX, INC. - INBX

10-02-2024
NEW ORLEANS--(BUSINESS WIRE)--FORMER ATTORNEY GENERAL OF LOUISIANA CHARLES C. FOTI, JR., ESQ. AND TH...
Více zde

UNITHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER INHIBRX, INC. HAS OBTAINED A FAIR PRICE IN ITS TRANSACTION WITH SANOFI

23-01-2024
MILWAUKEE , JAN. 23, 2024 /PRNEWSWIRE/ -- ADEMI LLP IS INVESTIGATING INHIBRX (NASDAQ: INBX) IN CONNE...
Více zde

INBX STOCK ALERT: HALPER SADEH LLC IS INVESTIGATING WHETHER THE SALE OF INHIBRX, INC. IS FAIR TO SHAREHOLDERS

23-01-2024
NEW YORK--(BUSINESS WIRE)--HALPER SADEH LLC, AN INVESTOR RIGHTS LAW FIRM, IS INVESTIGATING WHETHER T...
Více zde

INHIBRX ANNOUNCES SALE OF INBRX-101 TO SANOFI FOR AN AGGREGATE VALUE OF UP TO $2.2B

23-01-2024
INHIBRX, INC. SHAREHOLDERS WILL RECEIVE PER SHARE CONSIDERATION OF $30 PER SHARE IN CASH, A CVR EQUA...
Více zde

INHIBRX ANNOUNCES PRELIMINARY DATA FROM THE PHASE 1 TRIAL OF INBRX-109 FOR THE TREATMENT OF EWING SARCOMA

02-11-2023
SAN DIEGO , NOV. 2, 2023 /PRNEWSWIRE/ -- INHIBRX, INC. (NASDAQ: INBX), A CLINICAL-STAGE BIOPHARMACEU...
Více zde

INHIBRX ANNOUNCES PARTICIPATION IN UPCOMING SCIENTIFIC CONFERENCES

18-10-2023
SAN DIEGO , OCT. 18, 2023 /PRNEWSWIRE/ -- INHIBRX, INC. (NASDAQ: INBX), A CLINICAL-STAGE BIOPHARMACE...
Více zde

INHIBRX RETAINS RIGHTS TO INBRX-101 FOR THE TREATMENT OF ALPHA-1 ANTITRYPSIN DEFICIENCY OUTSIDE OF THE UNITED STATES AND CANADA

19-09-2023
SAN DIEGO , SEPT. 19, 2023 /PRNEWSWIRE/ -- INHIBRX, INC. (NASDAQ: INBX), A CLINICAL-STAGE BIOPHARMAC...
Více zde

INHIBRX ANNOUNCES $200 MILLION PRIVATE PLACEMENT FINANCING

29-08-2023
SAN DIEGO , AUG. 29, 2023 /PRNEWSWIRE/ -- INHIBRX, INC. (NASDAQ: INBX) ("INHIBRX" OR THE "COMPANY"),...
Více zde

INHIBRX REPORTS SECOND QUARTER 2023 FINANCIAL RESULTS AND RECENT CORPORATE HIGHLIGHTS

07-08-2023
SAN DIEGO , AUG. 7, 2023 /PRNEWSWIRE/ -- INHIBRX, INC. (NASDAQ: INBX), OR INHIBRX, OR THE COMPANY, A...
Více zde

INHIBRX GRANTED FAST TRACK DESIGNATION FOR INBRX-101 FOR THE TREATMENT OF ALPHA-1 ANTITRYPSIN DEFICIENCY

30-05-2023
SAN DIEGO , MAY 30, 2023 /PRNEWSWIRE/ -- INHIBRX, INC. (NASDAQ: INBX), A CLINICAL-STAGE BIOPHARMACEU...
Více zde

INHIBRX INITIATES A REGISTRATION-ENABLING TRIAL OF INBRX-101 IN AATD AND ANNOUNCES LIFT OF PARTIAL CLINICAL HOLD ON INBRX-109 DR5 AGONIST TRIALS

26-04-2023
SAN DIEGO , APRIL 26, 2023 /PRNEWSWIRE/ -- INHIBRX, INC. (NASDAQ: INBX), A CLINICAL-STAGE BIOPHARMAC...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2025-12-16 00:00:008-KStáhnout
2025-11-14 00:00:008-KStáhnout
2025-11-14 00:00:0010-QStáhnout
2025-10-23 01:00:008-KStáhnout
2025-10-23 00:00:008-KStáhnout
2025-08-13 01:00:008-KStáhnout
2025-08-13 01:00:0010-QStáhnout
2025-08-13 00:00:008-KStáhnout
2025-08-13 00:00:0010-QStáhnout
2025-05-28 01:00:008-KStáhnout
2025-05-28 00:00:008-KStáhnout
2025-05-14 01:00:008-KStáhnout
2025-05-14 01:00:0010-QStáhnout
2025-05-14 00:00:008-KStáhnout
2025-05-14 00:00:0010-QStáhnout
2025-04-01 01:00:008-KStáhnout
2025-04-01 00:00:008-KStáhnout
2025-03-17 00:00:008-KStáhnout
2025-03-17 00:00:0010-KStáhnout
2025-03-16 23:00:008-KStáhnout
2025-03-16 23:00:0010-KStáhnout
2025-01-21 00:00:008-KStáhnout
2025-01-20 23:00:008-KStáhnout
2025-01-13 00:00:008-KStáhnout
2025-01-12 23:00:008-KStáhnout
2024-11-14 00:00:008-KStáhnout
2024-11-14 00:00:0010-QStáhnout
2024-11-13 23:00:008-KStáhnout
2024-11-13 23:00:0010-QStáhnout
2024-11-04 00:00:008-KStáhnout
2024-11-03 23:00:008-KStáhnout
2024-08-13 01:00:008-KStáhnout
2024-08-13 01:00:0010-QStáhnout
2024-08-13 00:00:008-KStáhnout
2024-08-13 00:00:0010-QStáhnout
2024-06-17 01:00:008-KStáhnout
2024-06-17 00:00:008-KStáhnout
2024-05-30 01:00:008-KStáhnout
2024-05-30 00:00:008-KStáhnout
2024-05-24 01:00:008-KStáhnout
2024-05-24 00:00:008-KStáhnout
2024-05-17 01:00:008-KStáhnout
2024-05-17 00:00:008-KStáhnout
2024-05-09 01:00:008-KStáhnout
2024-05-09 01:00:0010-QStáhnout
2024-05-09 00:00:008-KStáhnout
2024-05-09 00:00:0010-QStáhnout
2024-05-08 01:00:008-KStáhnout
2024-05-08 00:00:008-KStáhnout
2024-03-12 00:00:008-KStáhnout
2024-03-11 23:00:008-KStáhnout
2024-02-28 00:00:008-KStáhnout
2024-02-28 00:00:0010-KStáhnout
2024-02-27 23:00:008-KStáhnout
2024-02-27 23:00:0010-KStáhnout
2024-01-23 00:00:008-KStáhnout
2024-01-22 23:00:008-KStáhnout
2023-11-09 00:00:008-KStáhnout
2023-11-09 00:00:0010-QStáhnout
2023-11-08 23:00:008-KStáhnout
2023-11-08 23:00:0010-QStáhnout
2023-11-02 00:00:008-KStáhnout
2023-11-01 23:00:008-KStáhnout
2023-09-19 01:00:008-KStáhnout
2023-09-19 00:00:008-KStáhnout
2023-08-29 01:00:008-KStáhnout
2023-08-29 00:00:008-KStáhnout
2023-08-07 01:00:008-KStáhnout
2023-08-07 01:00:0010-QStáhnout
2023-08-07 00:00:008-KStáhnout
2023-08-07 00:00:0010-QStáhnout
2023-05-30 01:00:008-KStáhnout
2023-05-30 00:00:008-KStáhnout
2023-05-25 01:00:008-KStáhnout
2023-05-25 00:00:008-KStáhnout
2023-05-08 01:00:008-KStáhnout
2023-05-08 01:00:0010-QStáhnout
2023-05-08 00:00:008-KStáhnout
2023-05-08 00:00:0010-QStáhnout
2023-04-26 01:00:008-KStáhnout
2023-04-26 00:00:008-KStáhnout
2023-03-13 00:00:008-KStáhnout
2023-03-12 23:00:008-KStáhnout
2023-03-06 00:00:008-KStáhnout
2023-03-06 00:00:0010-KStáhnout
2023-03-05 23:00:008-KStáhnout
2023-03-05 23:00:0010-KStáhnout
2022-11-16 00:00:008-KStáhnout
2022-11-15 23:00:008-KStáhnout
2022-11-07 00:00:008-KStáhnout
2022-11-07 00:00:0010-QStáhnout
2022-11-06 23:00:008-KStáhnout
2022-11-06 23:00:0010-QStáhnout
2022-10-26 01:00:008-KStáhnout
2022-10-26 00:00:008-KStáhnout
2022-10-04 01:00:008-KStáhnout
2022-10-04 00:00:008-KStáhnout
2022-08-15 01:00:008-KStáhnout
2022-08-15 00:00:008-KStáhnout
2022-08-10 01:00:008-KStáhnout
2022-08-10 00:00:008-KStáhnout
2022-08-08 01:00:008-KStáhnout
2022-08-08 01:00:0010-QStáhnout
2022-08-08 00:00:008-KStáhnout
2022-08-08 00:00:0010-QStáhnout
2022-06-30 01:00:008-KStáhnout
2022-06-30 00:00:008-KStáhnout
2022-06-16 01:00:008-KStáhnout
2022-06-16 00:00:008-KStáhnout
2022-05-25 01:00:008-KStáhnout
2022-05-25 00:00:008-KStáhnout
2022-05-16 01:00:008-KStáhnout
2022-05-16 00:00:008-KStáhnout
2022-05-09 01:00:008-KStáhnout
2022-05-09 01:00:0010-QStáhnout
2022-05-09 00:00:008-KStáhnout
2022-05-09 00:00:0010-QStáhnout
2022-04-25 01:00:008-KStáhnout
2022-04-25 00:00:008-KStáhnout
2022-04-05 01:00:008-KStáhnout
2022-04-05 00:00:008-KStáhnout
2022-04-04 01:00:008-KStáhnout
2022-04-04 00:00:008-KStáhnout
2022-03-03 00:00:008-KStáhnout
2022-03-02 23:00:008-KStáhnout
2022-02-28 00:00:008-KStáhnout
2022-02-28 00:00:0010-KStáhnout
2022-02-27 23:00:008-KStáhnout
2022-02-27 23:00:0010-KStáhnout
2022-02-22 00:00:008-KStáhnout
2022-02-21 23:00:008-KStáhnout
2022-01-25 00:00:008-KStáhnout
2022-01-24 23:00:008-KStáhnout
2022-01-04 00:00:008-KStáhnout
2022-01-03 23:00:008-KStáhnout
2021-12-01 00:00:008-KStáhnout
2021-11-30 23:00:008-KStáhnout
2021-11-09 00:00:008-KStáhnout
2021-11-09 00:00:0010-QStáhnout
2021-11-08 23:00:008-KStáhnout
2021-11-08 23:00:0010-QStáhnout
2021-10-28 01:00:008-KStáhnout
2021-10-28 00:00:008-KStáhnout
2021-10-12 01:00:008-KStáhnout
2021-10-12 00:00:008-KStáhnout
2021-09-03 01:00:008-KStáhnout
2021-09-03 00:00:008-KStáhnout
2021-08-09 01:00:008-KStáhnout
2021-08-09 01:00:0010-QStáhnout
2021-08-09 00:00:008-KStáhnout
2021-08-09 00:00:0010-QStáhnout
2021-06-21 01:00:008-KStáhnout
2021-06-21 00:00:008-KStáhnout
2021-06-09 01:00:008-KStáhnout
2021-06-09 00:00:008-KStáhnout
2021-05-13 01:00:008-KStáhnout
2021-05-13 01:00:0010-QStáhnout
2021-05-13 00:00:008-KStáhnout
2021-05-13 00:00:0010-QStáhnout
2021-03-12 00:00:008-KStáhnout
2021-03-12 00:00:0010-KStáhnout
2021-03-11 23:00:008-KStáhnout
2021-03-11 23:00:0010-KStáhnout
2021-01-13 00:00:008-KStáhnout
2021-01-12 23:00:008-KStáhnout
2021-01-05 00:00:008-KStáhnout
2021-01-04 23:00:008-KStáhnout
2020-11-13 00:00:008-KStáhnout
2020-11-13 00:00:0010-QStáhnout
2020-11-12 23:00:008-KStáhnout
2020-11-12 23:00:0010-QStáhnout
2020-11-12 00:00:008-KStáhnout
2020-11-11 23:00:008-KStáhnout
2020-09-11 01:00:008-KStáhnout
2020-09-11 00:00:008-KStáhnout
2020-08-21 01:00:008-KStáhnout
2020-08-21 00:00:008-KStáhnout
preloader